Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline
Clinical trial NCT02115256 · TERMINATED
Trial details
- NCT number
- NCT02115256
- Sponsor
- Yaakov Beilin
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-04-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.